IGC Pharma Inc. has reported preclinical research demonstrating the therapeutic potential of IGC-1C, a cyclic dipeptide-based small-molecule modulator, in neurodegenerative disease due to its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback